{"id":3788,"date":"2021-10-05T08:58:13","date_gmt":"2021-10-05T08:58:13","guid":{"rendered":"https:\/\/topdiag.com\/?p=3788"},"modified":"2021-10-05T10:22:25","modified_gmt":"2021-10-05T10:22:25","slug":"trombocitopenia-indusa-de-vaccin-vitt-fiziopatologia-diagnosticul-si-managementul-complicatiilor-rare-ale-vaccinarii-covid-19-un-nou-webinar-stago","status":"publish","type":"post","link":"https:\/\/topdiag.com\/ro\/2021\/10\/05\/trombocitopenia-indusa-de-vaccin-vitt-fiziopatologia-diagnosticul-si-managementul-complicatiilor-rare-ale-vaccinarii-covid-19-un-nou-webinar-stago\/","title":{"rendered":"&#8222;Trombocitopenia indus\u0103 de vaccin (VITT): fiziopatologia, diagnosticul \u0219i managementul complica\u021biilor rare ale vaccin\u0103rii anti COVID-19&#8221;  &#8211; un nou webinar Stago"},"content":{"rendered":"<blockquote><p>Top Diagnostics anun\u021b\u0103 urm\u0103torul webinar Stago cu tema <strong>&#8222;Trombocitopenia indus\u0103 de vaccin (VITT): fiziopatologia, diagnosticul \u0219i managementul complica\u021biilor rare ale vaccin\u0103rii anti COVID-19&#8221;. <\/strong>Webinarul va fi sus\u021binut de <strong>prof. Yves Gruel, mar\u021bi, 5 octombrie 2021.<\/strong><\/p><\/blockquote>\n<p>De la declan\u0219area pandemiei de Coronavirus 2019 (COVID-19), provocat\u0103 de virusul SARS-CoV-2, au fost raportate peste 200 milioane de cazuri de infectare la nivel mondial, cu o rat\u0103 a mortalit\u0103\u021bii de aproximativ 2%. Dezvoltarea de vaccinuri capabile s\u0103 contracareze boala COVID-19, spitaliz\u0103rile \u0219i decesele asociate, a fost fundamental\u0103. Vaccinarea este esen\u021bial\u0103 pentru a opri eficient pandemia. Baz\u00e2ndu-se pe cuno\u0219tin\u021bele deja existente, dezvoltarea vaccinurilor COVID-19 s-a accelerat cu o vitez\u0103 inimaginabil\u0103, permit\u00e2nd vaccinarea a peste 2.5 miliarde de persoane. La marea majoritate a persoanelor vaccinate nu au fost observate efecte secundare, sau cele ap\u0103rute au fost benigne. Cu toate acestea, \u00een anumite cazuri extrem de rare, unele persoane vaccinate pot prezenta un efect advers care poate pune via\u021ba \u00een pericol, \u0219i anume trombocitopenia indus\u0103 de vaccin (VITT).<\/p>\n<p>\u00cen timpul acestui webinar, participan\u021bii vor afla despre mecanismele fiziopatologice implicate \u00een aceste manifest\u0103ri critice, precum \u0219i despre managementul clinic \u0219i de laborator al VITT.<\/p>\n<p><strong>Cum ne conect\u0103m?<\/strong><br \/>\nPentru \u00eenregistrarea la acest webinar, v\u0103 rug\u0103m s\u0103 accesa\u021bi:\u00a0<a href=\"http:\/\/www.stagowebinars.com\/\">www.stagowebinars.com<\/a><br \/>\nLa prima conectare trebuie s\u0103 v\u0103 \u00eenregistra\u021bi la rubrica \u201cRegister\u201d (d\u00e2nd informa\u0163ii generale despre dumneavoastr\u0103), iar dup\u0103 aceast\u0103 \u00eenregistrare pute\u0163i participa la webinar. Pentru toate conect\u0103rile ulterioare, da\u0163i click pe \u201cLIVE\u201d \u015fi introduce\u0163i adresa dumneavoastr\u0103 de e-mail.<br \/>\nSec\u0163iunea \u201cLIVE\u201d este dedicat\u0103 particip\u0103rii la eveniment, pentru a asculta \u00eentreb\u0103rile, precum \u0219i pentru a adresa \u00eentreb\u0103ri \u00een timp real.<br \/>\nSec\u021biunea \u201cWOD\u201d (Webinar On Demand) este dedicat\u0103 pentru a asculta ulterior \u00eenregistrarea evenimentului, \u00een cazul \u00een care nu pute\u021bi participa \u00een direct, sau dac\u0103 dori\u021bi s\u0103 reasculta\u021bi cele discutate \u00een cadrul teleconferin\u021bei.<\/p>\n<p><strong>Despre Prof. Yves Gruel<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-3789 size-thumbnail alignleft\" src=\"https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel-150x150.jpg 150w, https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel-300x300.jpg 300w, https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel-500x500.jpg 500w, https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel-250x250.jpg 250w, https:\/\/topdiag.com\/content\/uploads\/2021\/10\/Yves-Gruel.jpg 719w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Yves Gruel s-a n\u0103scut \u00een 1955 \u0219i este medic hematolog, iar din 1993 profesor universitar la Universitatea Fran\u00e7ois Rabelais din Tours. A studiat la Tours, dar \u0219i la Paris (1984-85) la unitatea Inserm U150 \u0219i \u00een Statele Unite la Institutul de Cercetare din cadrul Centrului de S\u00e2nge din Milwaukee (1991-92). A fost \u0219eful departamentului de hematologie-hemostaz\u0103 la spitalul Trosseau din Tours \u00eentre 1993 \u0219i 2018, desf\u0103\u0219ur\u00e2nd o activitate clinic\u0103 de cercetare concentrat\u0103 pe tulbur\u0103ri congenitale sau dob\u00e2ndite de hemostaz\u0103. Coordoneaz\u0103 Centrul de Competen\u021b\u0103 pentru hemofilie \u0219i boli hemoragice al Centrului regional din Tours.<\/p>\n<p>De asemeea, Yves Gruel a fost \u00eentre 2013 \u0219i 2019 Pre\u0219edinte al Grupului Francez de Studiu privind \u00a0Hemostaza \u0219i Tromboza (GFHT). El are o expertiz\u0103 interna\u021bional\u0103 \u00een imunologia plachetar\u0103, \u00een special \u00een trombocitopenia indus\u0103 de heparin\u0103. A fost, de asemenea, Pre\u0219edinte al Subcomitetului de Imunologie Plachetar\u0103 al Societ\u0103\u021bii Interna\u021bionale de Hemostaz\u0103 \u0219i Tromboz\u0103 (ISTH). \u00a0Este coautorul a peste 200 de articole \u0219tiintifice \u0219i medicale publicate \u00een reviste interna\u021bionale precum &#8222;Blood&#8221;, &#8222;Circulation&#8221;, &#8222;Journal of Thrombosis and Haemostasis&#8221; sau &#8222;Thrombosis and Haemostasis&#8221; . \u00cen prezent este redactor \u0219ef la Revue francophone d\u2019H\u00e9mostase et Thrombose.<\/p>\n<p><strong>Despre Diagnostica<\/strong>\u00a0<strong>Stago<\/strong><br \/>\nStago este o companie interna\u021bional\u0103 \u00eenfiin\u021bat\u0103 \u00een anul 1945, \u00een Fran\u021ba \u0219i este singura companie din industria diagnosticului in-vitro specializat\u0103 exclusiv \u00een explor\u0103rile de hemostaz\u0103 \u0219i tromboz\u0103, cu un portofoliu de peste 350 de produse:\u00a0<a href=\"http:\/\/topdiag.com\/ro\/product\/?manufacturer[]=1472\">analizoare, reactivi \u0219i consumabile<\/a>. \u00cen laboratoarele sale de R&amp;D, Stago a dezvoltat metoda de detec\u021bie v\u00e2scozimetric\u0103, considerat\u0103 \u201egold standard\u201d pentru analiza plasmei, v\u00e2scozimetria fiind independent\u0103 de opalescen\u021ba reactivului precum \u0219i de culoarea plasmei, fie c\u0103 este hemolizat\u0103, lipemic\u0103 sau icteric\u0103.<\/p>\n<p>Pentru orice informa\u021bie suplimentar\u0103 v\u0103 st\u0103m la dispozi\u021bie la:\u00a0<a href=\"mailto:marketing@topdiag.com?subject=Webinar%20Stago\">marketing@topdiag.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Top Diagnostics anun\u021b\u0103 urm\u0103torul webinar Stago cu tema &#8222;Trombocitopenia indus\u0103 de vaccin (VITT): fiziopatologia, diagnosticul \u0219i managementul complica\u021biilor rare ale vaccin\u0103rii anti COVID-19&#8221;. Webinarul va fi sus\u021binut de prof. Yves Gruel, mar\u021bi, 5 octombrie 2021. De la declan\u0219area pandemiei de Coronavirus 2019 (COVID-19), provocat\u0103 de virusul SARS-CoV-2, au fost raportate peste 200 milioane de cazuri [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3018,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,3],"tags":[],"class_list":["post-3788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-events"],"_links":{"self":[{"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/posts\/3788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/comments?post=3788"}],"version-history":[{"count":13,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/posts\/3788\/revisions"}],"predecessor-version":[{"id":3802,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/posts\/3788\/revisions\/3802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/media\/3018"}],"wp:attachment":[{"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/media?parent=3788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/categories?post=3788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/topdiag.com\/ro\/wp-json\/wp\/v2\/tags?post=3788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}